Saturday, October 11, 2014: 2:10 PM
Inês Correia-Sá, MD
,
Department of Plastic and Reconstructive Surgery, Faculty of Medicine, University of Porto and Centro Hospitalar São João, Porto, Portugal
Paula Serrão, MD
,
Department of Pharmacology and Therapeutic, Faculty of Medicine, University of Porto, Porto, Portugal
Marisa Marques, MD, PhD
,
Department of Plastic and Reconstructive Surgery, Faculty of Medicine, University of Porto and Centro Hospitalar São João, Porto, Portugal
Maria A. Vieira-Coelho, MD, PhD
,
Department of Pharmacology and Therapeutic, Faculty of Medicine, University of Porto, Porto, Portugal
Objectives: Hypertrophic scars and keloids represent common undesirable consequences of
wound-healing in which the pathogenesis continues on debate. It is known that a
robust inflammatory mechanism is behind the formation of this abnormal fibrous wound-healing process.
However, specific etiology, and pathophysiology
remains unknown and treatment
options ineffective[1]. Vitamin D is involved
in proliferation, differentiation, and immunoregulation
of cells and has shown to be a powerful anti-inflammatory agent[2].
Moreover, Vitamin D plays a role in terminal differentiation of epidermal cells
that can affect wound healing[3,4]. The aim of this
study is to evaluate vitamin D and inflammatory biomarkers plasma levels during
wound-healing. Materials and Methods: A prospective study was performed in patients (n=50)
submitted to body contouring surgery, regarding the clinical evolution of the
scars. Blood samples were collected before (t0) and 3 to 5 days
after surgery (t5) corresponding to the inflammatory phase of wound
healing. Blood cell count, protein
inflammatory biomarkers, vitamin D, vitamin A and vitamin E were quantified.
Three months after surgery scars were evaluated and classified as normal or
hypertrophic by two independent observers.
Results: In the end of the study 80%
of patients developed a normal scar (control group, n=40) and 20% of patients
presented hypertrophic scars (HT group, n=10). Patients in the HT group presented higher monocyte
count (8.55% vs. 7.19%, p=0.036) and C-reactive protein levels (CRP: 6.12mg/L
and 2.30mg/L, p=0.015) in t0 comparing with the control group. In t5,
patients in the HT group, showed an decrease in neutrophil (53.97% vs 61,55%, p=0.0065) and increase in basophil (0.45% vs. 0.22%,
p=0.0003) and lymphocyte count (32.47%
vs. 27.11%, p=0.037) compared with patients with normal scars (Fig.1).
Before surgery, Vitamin D plasma levels were found to
be decreased by almost 50% (23.96ng/ml vs 13.33ng/mL, p=0.06) in patients that
developed hypertrophic scars., in contrast no differences were found in vitamin
E and vitamin A levels (Fig.2).Conclusion: There is different systemic inflammatory profile
response in patient during the formation of hypertrophic scars. Furthermore,
vitamin D plasma levels are marked reduced in these patients. Considering the
powerful anti-inflammatory effect of Vitamin D these findings could be related.